As of 2025-11-07, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -11.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 1,791.03 mil USD. Novocure's TTM EBITDA according to its financial statements is -156.85 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 9.4x | 7.8x |
| Forward P/E multiples | 19.3x - 22.4x | 20.3x |
| Fair Price | (31.88) - (17.94) | (24.46) |
| Upside | -382.9% - -259.2% | -317.0% |
| Date | EV/EBITDA |
| 2025-11-05 | -11.66 |
| 2025-11-04 | -11.94 |
| 2025-11-03 | -12.10 |
| 2025-10-31 | -12.52 |
| 2025-10-30 | -12.52 |
| 2025-10-29 | -12.99 |
| 2025-10-28 | -12.92 |
| 2025-10-27 | -13.07 |
| 2025-10-24 | -13.19 |
| 2025-10-23 | -13.31 |
| 2025-10-22 | -13.26 |
| 2025-10-21 | -13.46 |
| 2025-10-20 | -13.71 |
| 2025-10-17 | -13.21 |
| 2025-10-16 | -13.39 |
| 2025-10-15 | -13.49 |
| 2025-10-14 | -12.77 |
| 2025-10-13 | -12.82 |
| 2025-10-10 | -13.00 |
| 2025-10-09 | -13.60 |
| 2025-10-08 | -13.61 |
| 2025-10-07 | -13.48 |
| 2025-10-06 | -13.72 |
| 2025-10-03 | -13.83 |
| 2025-10-02 | -13.40 |
| 2025-10-01 | -13.35 |
| 2025-09-30 | -12.59 |
| 2025-09-29 | -12.59 |
| 2025-09-26 | -12.57 |
| 2025-09-25 | -12.49 |
| 2025-09-24 | -12.54 |
| 2025-09-23 | -12.65 |
| 2025-09-22 | -12.72 |
| 2025-09-19 | -12.43 |
| 2025-09-18 | -12.65 |
| 2025-09-17 | -12.43 |
| 2025-09-16 | -12.42 |
| 2025-09-15 | -12.45 |
| 2025-09-12 | -12.05 |
| 2025-09-11 | -12.46 |
| 2025-09-10 | -12.09 |
| 2025-09-09 | -12.41 |
| 2025-09-08 | -12.37 |
| 2025-09-05 | -12.14 |
| 2025-09-04 | -11.92 |
| 2025-09-03 | -12.00 |
| 2025-09-02 | -12.07 |
| 2025-08-29 | -12.17 |
| 2025-08-28 | -11.96 |
| 2025-08-27 | -11.87 |